Last reviewed · How we verify
NCT07018167
Impact of Door-to-Needle Time on Stroke Outcomes at Gonesse Hospital
trial in Stroke in 61 participants. Participants enrolled and being followed up; not accepting new ones.
1 September 2025
Quick facts
| Lead sponsor | Centre Hospitalier de Gonesse |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 61 |
| Start date | 1 May 2025 |
| Primary completion | 1 September 2025 |
| Estimated completion | 1 September 2025 |
| Sites | 1 location across France |
Conditions studied
- Stroke — all drugs for Stroke →
- Ischemic Attack, Transient — all drugs for Ischemic Attack, Transient →
- Cerebral Infarction — all drugs for Cerebral Infarction →
- Thrombolytic Therapy — all drugs for Thrombolytic Therapy →
Sponsor
Centre Hospitalier de Gonesse
Who can join
Eligibility, any sex, with Stroke or Ischemic Attack, Transient. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study looks at how quickly stroke patients receive treatment after arriving at Gonesse Hospital and whether this affects their recovery. Researchers will measure the time between a patient's arrival and the start of clot-busting treatment (called Door-to-Needle Time), as well as the time from symptom onset to hospital arrival (Home-Time). The goal is to see if treatment delays impact recovery, and to find ways to improve stroke care in the hospital.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07018167
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other Centre Hospitalier de Gonesse trials
Trials by the same sponsor.
- NCT07172542 — High Risk of Death or Disability in Brain Hemorrhage: Role of Spot Sign and Secondary Markers · not yet recruiting
- NCT07122856 — Predictive Factors for Initial MMSE Score and Rapid Decline in Alzheimer's Disease Patients · not yet recruiting
- NCT07064265 — Assessment of Interprofessional Competencies of Healthcare Professionals Before and After Healthcare Simulation Sessions · not yet recruiting
- NCT07122869 — Eligibility of Patients Referred to Emergency Departments by Their General Practitioners for Care in Walk-in Clinics: A · recruiting
- NCT07030036 — Screening for Cognitive Disorders in Multiple Sclerosis · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07018167 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier de Gonesse
- Last refreshed: 12 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07018167.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing